Innovative Oncology Solutions launches three new fiducial markers for radiation oncology

Innovative Oncology Solutions unveiled three fiducial marker products designed to make radiation therapy planning and delivery more predictable. The launch targets common workflow issues in radiation oncology, with new options aimed at improving placement efficiency, imaging clarity and standardization.

Why it matters: - Radiation oncology teams depend on fiducial markers to guide imaging and treatment, so small differences in placement or visibility can affect planning and daily delivery. - IOS is targeting avoidable variation across simulation, planning and image-guided radiation therapy with a product set built for reproducibility. - The launch is meant to support clinicians, physicists, therapists and department leaders who need cleaner workflows without added complexity.

What happened: - Innovative Oncology Solutions announced three new fiducial marker products: Spaced Polymark, Spaced FusionCoil Silhouette and FusionCoil Silhouette in a non-spaced version. - The launch was announced July 2, 2026, from Byhalia, Mississippi. - David Holdford, IOS director of sales, said the launch is intended to help clinics reduce avoidable variation and make adoption easier across the care team.

The details: - Spaced Polymark delivers two low-density polymer fiducials through a single 18GA needle, separated by a bioabsorbable spacer. - IOS says Spaced Polymark is visible in MRI, CT, kV and CBCT. - Spaced Polymark is intended for image registration and for photon and proton treatment environments. - IOS designed Spaced Polymark to minimize imaging artifact and support imaging clarity during planning and image fusion. - Spaced FusionCoil Silhouette delivers two 0.6mm diameter helical gold coil markers with titanium alloy cores through a single 20GA needle, separated by a bioabsorbable spacer. - IOS says the spaced FusionCoil Silhouette is visible across CT, kV, CBCT and MRI. - IOS says the spaced FusionCoil Silhouette is designed to support image fusion and tracking while allowing defined spacing with fewer needle sticks. - FusionCoil Silhouette is also available as a non-spaced single-marker option for cases that call for that approach. - IOS says the full lineup is built for efficient placement, imaging clarity and reproducibility.

Between the lines: - The launch reflects a push to reduce friction between procedure, planning and treatment delivery, not just add another marker option. - The spacing and non-spacing choices give clinics more flexibility to match procedural preference and case requirements. - The focus on visibility across MRI, CT, kV and CBCT suggests IOS is aiming at workflows where multimodality imaging matters. - The product set also fits a broader trend in radiation oncology toward standardization that does not slow down daily operations.

What's next: - IOS will exhibit at the ASTRO 2026 Annual Meeting from September 27 to 29, 2026. - Clinics can request samples, ask about the new fiducial marker portfolio, request the full IOS product catalog or schedule a meeting with David Holdford. - More information is available by email at info@innovativeoncology.com or by phone at 800-993-0928. - IOS says the new fiducial marker lineup is part of its broader radiation oncology portfolio, which includes positioning, immobilization, fiducials, bolus and treatment accessories.

The bottom line: - IOS is betting that better marker design can make radiation therapy setups more consistent, easier to execute and less prone to avoidable variation.